LEEANN BRUNS: Open Payments
NPI 1972048379 · CHADRON, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$173 in 8 payments from 6 companies in 2025. Trend: 2023 $18 · 2024 $49 · 2025 $173
Food & beverage: $173
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $59 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| ABBVIE INC. | 1 | $25 |
| Iovance Biotherapeutics, Inc. | 1 | $25 |
| Verona Pharma, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $13 |
Products named: MOUNJARO, GVOKE HYPOPEN, VRAYLAR, Amtagvi, Ohtuvayre, TAVNEOS.
Industry payments across NE — which companies pay providers there.
